Accelerate Your Gene Therapy Research

Between 2014 and 2021, the use of qPCR, dPCR, Sanger sequencing, or microarray technologies for genetic analysis in clinical trials increased by 56%.

Whether your key vector strategy is based on adenoviruses (AV), adeno-associated viruses (AAV) or lentiviruses (LV), these genetic analysis tools are enabling researchers to develop safer gene therapies – with greater speed and confidence.

Download this infographic to discover how genetic analysis can help you:

• Rapidly identify molecular lesions 
• Maximize the performance of your transgene delivery vehicles
  
• Gain confidence in your preclinical studies